Meagan Ashley Short, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 6 years
- Graduated 2020
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Meagan Ashley Short’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$495
Pharmacies billed $495 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 14) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
$495 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 14 | None | 0% (0) | None | $495 |
| 2023 | 20 | None | 0% (0) | None | $2,088 |
| 2022 | 40 | 22 | 0% (0) | None | $4,038 |
| 2021 | 39 | 12 | 0% (0) | None | $993 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$83 in 2023
| 2023 | 1 | 4 | None | $83 |
| 2022 | 15 | 32 | None | $950 |
| 2021 | 23 | 121 | None | $2,202 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Qulipta | $83 | 4 payments
|
See all 4 published payments
| Abbvie | Meals · 2023-09-19 | Qulipta | $14 |
| Abbvie | Meals · 2023-08-22 | Qulipta | $24 |
| Abbvie | Meals · 2023-07-27 | Ubrelvy | $15 |
| Abbvie | Meals · 2023-05-22 | Qulipta | $30 |
See earlier years (2022, 2021)
2022: $950
| Abbvie | Vraylar | $209 | 8 payments
|
| Novo Nordisk | Saxenda | $159 | 6 payments
|
| Neos Therapeutics LP | Adzenys Xr-Odt | $150 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $140 | 3 payments
|
| Coloplast | Titan | $76 | 1 payment
|
| Amarin Pharma | Vascepa | $39 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $35 | 2 payments
|
| Amneal Pharmaceuticals | Unithroid | $24 | 1 payment
|
| Amgen | Evenity | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $18 | 1 payment
|
| ViiV Healthcare | Apretude | $18 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $18 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $14 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $12 | 1 payment
|
2021: $2,202
| Novo Nordisk | Wegovy | $370 | 16 payments
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $226 | 15 payments
|
| Amgen | Aimovig | $193 | 13 payments
|
| Amarin Pharma | Vascepa | $191 | 9 payments
|
| AbbVie | Ubrelvy | $179 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $163 | 5 payments
|
| Jazz Pharmaceuticals | Sunosi | $119 | 6 payments
|
| Eisai | Dayvigo | $112 | 7 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $92 | 5 payments
|
| Astellas Pharma US | Myrbetriq | $85 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $77 | 4 payments
|
| Neos Therapeutics LP | Adzenys Xr-Odt | $75 | 4 payments
|
| Upsher-Smith Laboratories | Tosymra | $53 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $49 | 3 payments
|
| Pfizer | Premarin | $40 | 3 payments
|
| Kowa Pharmaceuticals America | Livalo | $34 | 3 payments
|
| Esperion Therapeutics | Nexletol | $32 | 2 payments
|
| Bausch Health US | Wellbutrin | $29 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $28 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $16 | 1 payment
|
| Currax Pharmaceuticals | Contrave | $15 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $12 | 1 payment
|
| Gilead Sciences | Descovy | $11 | 1 payment
|
Professional record
- NPI
- 1033737754
- Licence
- GA 268355
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2020-07-09
- NPI last updated
- 2024-09-10
- NPI record certified
- 2024-09-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 993 Johnson Fy Rd Ne Ste F210, Atlanta, GA, 30342